USPTO serial 88719898
BIOINTELLISENSE
Reviewed by CopyMark Law Group
Status 603
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, BRIDGETT G
- Law office
- TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIOINTELLISENSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
KATHERINE P. CALIFA
KATHERINE P. CALIFA FOLEY & LARDNER LLP3000 K STREET NWSIXTH FLOORWASHINGTON, DC 20007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software in the fields of healthcare, medicine and wellness for use in patient communication, patient care, dynamic collection of patient related health and wellness data, care coordination and care management, chronic disease management, remote patient monitoring and engagement between health care providers and patients; providing downloadable mobile application featuring technology that enables care providers and users to enter, access, track, monitor and generate health and medical information and reports; none of the foregoing for use in connection with blood pressure monitors | ACTIVE | — |
| 042 | Data-as-a-service (DAAS) services featuring software for collection, verification, aggregation, storage, management, distribution, transmission, and visualization of health-related data; software as a service (SAAS) services featuring software for integrating and analyzing patient health data for predictive analysis of health risks and health events; providing an interactive web platform featuring technology that enables care providers and users to enter, access, track, monitor and generate health and medical information and reports; providing a (computer software) cloud-based analytics platform for recording, transmitting, analyzing and reporting patient health data and clinical insights to care providers; Platform as a service (PAAS) featuring a computer software platform in the fields of healthcare, medicine and wellness for patient communication, patient care, dynamic collection of patient related health and wellness data, care coordination and care management, chronic disease management, remote patient monitoring and engagement between health care providers and patients; Software as a service (SAAS) featuring software in the fields of healthcare, medicine and wellness for the purpose of providing an integrated health management system using machine learning and artificial intelligence, namely, software for providing patients and health care providers access to patient information and data, for dynamic collection of patient related health and wellness data, and for providing patients access to personalized information relevant to patient health and wellbeing; providing non-downloadable interactive web-based application featuring technology that enables care providers and users to enter, access, track, monitor and generate health and medical information and reports; none of the foregoing for use in connection with blood pressure monitors | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2021 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Sep 27, 2021 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| Sep 27, 2021 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Aug 18, 2021 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Jun 1, 2021 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jun 1, 2021 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jun 1, 2021 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Apr 27, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 27, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2021 | ALIE | ASSIGNED TO LIE | — |
| Apr 22, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 22, 2021 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Apr 22, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 22, 2021 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Dec 16, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 16, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 16, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 23, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 23, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 23, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 17, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 17, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 20, 2020 | CEPE | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | — |
| Mar 20, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 20, 2020 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 20, 2020 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 20, 2020 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Mar 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 12, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 12, 2019 | NWAP | NEW APPLICATION ENTERED | — |